Marketwatch Cadila Healthcare gains 3% as DCGI plays phase III trials of Covid vaccine Admin January 4, 2021 The company will now be initiating Phase III clinical trials in around 30,000 volunteers. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
